Anesthesiology, Pain Medicine · Bossier City, LA
NPI
1841580776
Since 2011
Specialty
Anesthesiology, Pain Medicine
Code 207LP2900X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
2449 Hospital Dr, Suite 300
Bossier City, LA, 71111
Phone (318) 212-7960
Groups this clinician bills Medicare through
Medicare paid, 2024
$559K
25,454 services
Medicare patients, 2024
1,057
Average age 73
Drug cost, 2024
$925K
14,447 prescriptions
Company payments, 2025
$840
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by David E Hirsch was code J1010 (injection, methylprednisolone acetate, 1 mg), 9,522 times for 179 patients. In total David E Hirsch billed 25,454 services in 63 codes, and Medicare paid $559K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2016-07-27.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J1010 Injection, methylprednisolone acetate, 1 mg | Office | 9,522 | 179 | $0.10 | $954 |
| J1100 Injection, dexamethasone sodium phosphate, 1 mg | Office | 3,981 | 260 | $0.09 | $353 |
| 99214 Office E&M - Established | Office | 1,331 | 558 | $82.81 | $110K |
| Q9966 Low osmolar contrast material, 200-299 mg/ml iodine concentration, per ml | Office | 855 | 205 | $0.28 | $240 |
| 80305 Drug Tests | Office | 747 | 475 | $12.12 | $9,057 |
| Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | Office | 342 | 100 | $0.11 | $36.98 |
| 64483 Nerve Block Injection - Back | Office | 283 | 197 | $196.47 | $56K |
| 64484 Nerve Block Injection - Back | Office | 169 | 128 | $81.51 | $14K |
| 64635 Destruction by Neurolytic Agent - Back | Office | 166 | 151 | $458.72 | $76K |
| 64636 Destruction by Neurolytic Agent - Back | Office | 154 | 142 | $258.08 | $40K |
| 64493 Nerve Block Injection - Back | Office | 153 | 87 | $179.25 | $27K |
| 64483 Nerve Block Injection - Back | Facility | 151 | 129 | $93.18 | $14K |
| 64494 Nerve Block Injection - Back | Office | 148 | 85 | $100.21 | $15K |
| 64493 Nerve Block Injection - Back | Facility | 81 | 43 | $96.88 | $7,847 |
| 99204 Office E&M - New | Office | 71 | 71 | $105.68 | $7,503 |
By year: 2022 $597K for 11,314 services; 2023 $590K for 12,071 services; 2024 $559K for 25,454 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 80305 Drug Tests | 747 | 475 | $12.12 | $9,057 |
Medicare prescription drug claims, 2024
In 2024, the drug David E Hirsch prescribed most often to Medicare patients was Hydrocodone-Acetaminophen (Hydrocodone/Acetaminophen), with 3,350 prescriptions and refills. In total David E Hirsch wrote 14,447 Medicare prescriptions that cost $925K.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Hydrocodone-Acetaminophen Hydrocodone/Acetaminophen | 3,350 | 3,352 | 559 | $67K |
| Oxycodone-Acetaminophen Oxycodone Hcl/Acetaminophen | 1,694 | 1,699 | 295 | $47K |
| Gabapentin Generic | 1,288 | 1,635 | 309 | $13K |
| Tramadol Hcl Generic | 969 | 975 | 224 | $6,443 |
| Pregabalin Generic | 861 | 908 | 213 | $10K |
| Tramadol Hcl Er Tramadol Hcl | 779 | 781 | 166 | $47K |
| Buprenorphine Generic | 718 | 718 | 196 | $137K |
| Diclofenac Sodium Generic | 541 | 661 | 149 | $7,684 |
| Oxycodone Hcl Generic | 434 | 434 | 72 | $11K |
| Methocarbamol Generic | 432 | 547 | 136 | $3,719 |
| Cyclobenzaprine Hcl Generic | 368 | 441 | 98 | $2,161 |
| Tizanidine Hcl Generic | 315 | 390 | 84 | $1,915 |
| Belbuca Buprenorphine Hcl | 299 | 309 | 80 | $220K |
| Meloxicam Generic | 265 | 346 | 75 | $637 |
| Morphine Sulfate Er Morphine Sulfate | 262 | 262 | 43 | $6,011 |
Brand drugs: 710 claims; generic drugs: 13,737 claims; opioid claims: 9,075.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid David E Hirsch $840 ($840 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbvie Inc. with $248.
| Company | Payments | Amount |
|---|---|---|
| Abbvie Inc. ABBV | 18 | $248 |
| Boston Scientific Corporation BSX | 7 | $172 |
| Pfizer Inc. PFE | 5 | $91.3 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC BHC | 3 | $58.5 |
| Averitas Pharma Inc. | 2 | $52.11 |
| Medtronic, Inc. MDT | 2 | $40.45 |
| Tonix Medicines, Inc. | 2 | $38.14 |
| Axsome Therapeutics, Inc. AXSM | 1 | $26.9 |
| Globus Medical, Inc. GMED | 1 | $24.57 |
| Abbott Laboratories ABT | 1 | $22.36 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.